<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Carney complex</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Carney complex</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Carney complex</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward W Cowen, MD, MHSc</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer L Hand, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 24, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4047542824"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Carney complex (CNC; MIM #160980) is a rare multiple endocrine neoplasia syndrome characterized by distinctive pigmented lesions of the skin and mucosal surfaces, cardiac and noncardiac myxomatous tumors, and multiple endocrine tumors [<a href="#rid1">1,2</a>]. CNC is most frequently associated with mutations in the protein kinase A type I-alpha regulatory subunit gene<em> </em>(<em>PRKAR1A</em>) and is inherited in an autosomal dominant fashion. Approximately 25 percent of cases occur sporadically, as a result of a de novo mutation.</p><p>CNC has been previously called NAME (<strong>n</strong>evi, <strong>a</strong>trial <strong>m</strong>yxoma, <strong>e</strong>phelides) and LAMB (<strong>l</strong>entigines, <strong>a</strong>trial <strong>m</strong>yxoma, <strong>b</strong>lue nevi) syndrome. It should not be confused with the Carney triad, which consists of paragangliomas, gastric stromal tumors, and pulmonary chondromas [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/5231.html" rel="external">"Paragangliomas: Epidemiology, clinical presentation, diagnosis, and histology"</a> and  <a class="medical medical_review" href="/d/html/7745.html" rel="external">"Clinical presentation, diagnosis, and prognosis of gastrointestinal stromal tumors"</a>.)</p><p>This topic review will focus on the cutaneous manifestations, diagnosis, and differential diagnosis of CNC. Endocrine and nonendocrine tumors associated with CNC are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/152.html" rel="external">"Cushing syndrome due to primary pigmented nodular adrenocortical disease", section on 'Carney complex (CNC)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4881.html" rel="external">"Cardiac tumors", section on 'Myxomas'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2972.html" rel="external">"Testicular sex cord stromal tumors", section on 'Sertoli cell tumors'</a>.)</p><p></p><p class="headingAnchor" id="H1412497262"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>CNC is a rare condition, but over 750 patients have been described in many different ethnic groups [<a href="#rid1">1</a>]. Given the significant variability in the clinical manifestations, even within a given family, careful clinical evaluation of first-degree family members is warranted in presumed "sporadic" cases [<a href="#rid4">4</a>]. Familial transmission has been reported more frequently via the affected mother, suggesting a non-Mendelian inheritance or impaired male fertility of affected individuals [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/d/html/2897.html" rel="external">"Inheritance patterns of monogenic disorders (Mendelian and non-Mendelian)"</a>.)</p><p class="headingAnchor" id="H2568368106"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>CNC is inherited in an autosomal dominant pattern with high penetrance but heterogeneous expression. Approximately one-quarter of cases may be due to de novo mutations. Two genetic loci have been linked to CNC. Inactivating mutations in the protein kinase A type I-alpha regulatory subunit<em> </em>(<em>PRKAR1A</em>) gene on chromosome 17q22-24 are found in the majority of CNC patients [<a href="#rid5">5</a>]. A second locus on chromosome 2p16 is also associated with CNC (Carney complex type 2 [CNC2], MIM 605244). <em>PRKAR1A</em> mutations have been more frequently associated with pigmented skin lesions, myxomas, and early-onset thyroid and gonadal tumors [<a href="#rid6">6</a>].  </p><p class="headingAnchor" id="H2237191679"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H700064159"><span class="h2">Skin</span></p><p class="headingAnchor" id="H3449493231"><span class="h3">Pigmented lesions</span><span class="headingEndMark"> — </span>Lentiginous skin pigmentation is the most readily identifiable sign of CNC and is found in 70 to 80 percent of patients [<a href="#rid1">1</a>]. Lentigines are stable, well-demarcated, and small (typically &lt;5 mm) tan, brown, or black pigmented macules. In contrast with ephelides (freckles), which tend to be lighter in color and most prominent on the photo-exposed areas of the skin, lentigines may occur anywhere on the body and also on mucosal surfaces. Occasionally, dark to black lentigines have a so-called "ink spot" appearance, with the central pigmentation "bleeding" into the surrounding skin  (<a class="graphic graphic_picture graphicRef112132" href="/d/graphic/112132.html" rel="external">picture 1</a>) [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/5560.html" rel="external">"Benign pigmented skin lesions other than melanocytic nevi (moles)"</a>.)</p><p>Lentigines associated with CNC typically manifest in the first two decades of life, becoming more prominent at puberty, and may fade in adulthood [<a href="#rid8">8</a>]. They have a predominant centrofacial distribution with perioral and periocular  (<a class="graphic graphic_picture graphicRef112329" href="/d/graphic/112329.html" rel="external">picture 2</a>) accentuation but may also involve the chest, palms, fingers, and toes. Lentiginous pigmentation of the genital mucosa is common in women  (<a class="graphic graphic_picture graphicRef112129 graphicRef112130" href="/d/graphic/112129.html" rel="external">picture 3A-B</a>).</p><p>The presence of lentiginous macules on the vermilion borders of the lips, lid margin, and, in particular, on the lacrimal caruncle  (<a class="graphic graphic_picture graphicRef112311" href="/d/graphic/112311.html" rel="external">picture 4</a>) is uncommon in the general population and is therefore an important clue to the clinical diagnosis of CNC. Conjunctival pigmentation  (<a class="graphic graphic_picture graphicRef112312" href="/d/graphic/112312.html" rel="external">picture 5</a>) has been reported in approximately 25 percent of CNC patients [<a href="#rid9">9</a>]. </p><p>Blue nevi are intensely pigmented dark blue or gray papules  (<a class="graphic graphic_picture graphicRef112126 graphicRef112127" href="/d/graphic/112126.html" rel="external">picture 6A-B</a>) [<a href="#rid1">1</a>]. Multiple blue nevi are identified in approximately 40 percent of CNC patients. Blue nevi of a rare subtype characterized by epithelioid histology are frequently found in patients with CNC [<a href="#rid7">7</a>]. Although not specific to CNC, a finding of epithelioid blue nevi should alert the clinician to the possibility of a CNC diagnosis. </p><p>Café-au-lait macules, nevus spilus, and, rarely, Spitz nevus can also be seen in patients with CNC [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/4846.html" rel="external">"Acquired melanocytic nevi (moles)", section on 'Blue nevi'</a> and  <a class="medical medical_review" href="/d/html/13523.html" rel="external">"Spitz nevus and atypical Spitz tumors"</a>.)</p><p class="headingAnchor" id="H211943495"><span class="h3">Myxomas</span><span class="headingEndMark"> — </span>Cutaneous myxomas are benign dermal tumors presenting as sharply demarcated subcutaneous nodules, a few millimeters to 1.5 cm in diameter, that vary in color from skin-colored to translucent to blue and may be slightly raised above the skin or exophytic  (<a class="graphic graphic_picture graphicRef112112 graphicRef112113 graphicRef112123 graphicRef112124 graphicRef112125" href="/d/graphic/112112.html" rel="external">picture 7A-E</a>). Cutaneous myxomas are seen in less than one-half of CNC patients, but when histologically confirmed, strongly suggest the diagnosis of CNC. Lesions may be solitary or multiple and occur more often on the head, neck, and trunk. Common locations are the eyelids, external ear canal, and areolae.</p><p class="headingAnchor" id="H4267784306"><span class="h2">Endocrine tumors</span><span class="headingEndMark"> — </span>Endocrine abnormalities due to tumors of the adrenal and pituitary glands or testicular tumors are the most frequent systemic manifestations of CNC [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary pigmented nodular adrenocortical disease</strong> – Primary pigmented nodular adrenocortical disease (PPNAD), resulting in adrenocorticotropic hormone-independent overproduction of cortisol and Cushing's syndrome, occurs in 25 to 45 percent of all patients with CNC. It commonly presents with weight gain, hypertension, diabetes mellitus, striae, and easy bruising. In some patients, Cushing's syndrome may be subclinical or may be the only manifestation of CNC. (See  <a class="medical medical_review" href="/d/html/152.html" rel="external">"Cushing syndrome due to primary pigmented nodular adrenocortical disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asymptomatic growth hormone hypersecretion</strong> – Asymptomatic growth hormone (GH) hypersecretion occurs in approximately two-thirds of CNC patients, in most cases without imaging evidence of pituitary adenoma. Acromegaly due to GH-secreting pituitary adenomas occur in approximately 10 to 15 percent of CNC patients, usually in the third or fourth decade of life [<a href="#rid1">1</a>]. Gigantism resulting from increased GH secretion before puberty is rare. Tumors may be single or multiple and occasionally associated with mammosomatotroph hyperplasia [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/d/html/5855.html" rel="external">"Pituitary gigantism"</a> and  <a class="medical medical_review" href="/d/html/6633.html" rel="external">"Causes and clinical manifestations of acromegaly"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Large cell calcifying Sertoli cell tumor</strong> – Large cell calcifying Sertoli cell tumors (LCCSCTs) of the testicles develop in approximately 75 percent of male patients and may lead to gynecomastia in prepubertal boys due to increased aromatase conversion of androgens to estrogens, as well as premature epiphyseal fusion and induction of central precocious puberty [<a href="#rid1">1,11</a>]. The majority of LCCSCTs are benign. Malignancy is found in approximately 17 percent of LCCSCTs, especially in large tumors (&gt;4 cm) or in patients older than 20 years [<a href="#rid12">12,13</a>]. Indices of malignancy include size larger than 4 cm, significant nuclear atypia, &gt;3 per 10 high-power fields, tumor necrosis, and angiolymphatic invasion. (See  <a class="medical medical_review" href="/d/html/14310.html" rel="external">"Gynecomastia in children and adolescents", section on 'Tumors'</a> and  <a class="medical medical_review" href="/d/html/5812.html" rel="external">"Definition, etiology, and evaluation of precocious puberty", section on 'Males'</a> and  <a class="medical medical_review" href="/d/html/2972.html" rel="external">"Testicular sex cord stromal tumors", section on 'Sertoli cell tumors'</a>.)</p><p></p><p>Thyroid nodules occur in up to 75 percent of patients with CNC and typically develop early in life, with adenomatous disease reported in 25 percent of patients. However, patients with CNC are generally euthyroid. Thyroid cancer (papillary and follicular carcinoma) develops in less than 10 percent of patients [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/d/html/5835.html" rel="external">"Thyroid nodules and cancer in children"</a>.)</p><p>Ovarian cysts, serous cystadenoma, teratomas, and endometrioid carcinoma have also been reported in women with CNC [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/d/html/3204.html" rel="external">"Adnexal mass: Differential diagnosis", section on 'Serous or mucinous cystadenoma'</a> and  <a class="medical medical_review" href="/d/html/3241.html" rel="external">"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Histopathology", section on 'Endometrioid carcinoma'</a>.)</p><p class="headingAnchor" id="H309132482"><span class="h2">Nonendocrine tumors</span><span class="headingEndMark"> — </span>Highly characteristic, nonendocrine tumors associated with CNC include cardiac myxomas (most frequent), psammomatous melanotic schwannomas, breast myxomas and ductal adenomas, and osteochondromyxomas [<a href="#rid16">16-19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac myxomas</strong> – Approximately 3 to 10 percent of all cardiac myxomas are associated with CNC [<a href="#rid20">20,21</a>]. In contrast with sporadic cardiac myxomas, tumors associated with CNC tend to occur at a younger age and may develop simultaneously in multiple chambers of the heart [<a href="#rid21">21</a>]. A review of 319 CNC patients reported cardiac myxoma in 35 percent of females and 45 percent of males by age 30. Forty-four percent of patients had recurrences [<a href="#rid22">22</a>]. Cardiac myxomas are friable and may present as a painful arterial embolism in a previously well patient. Symptoms of cardiac outflow obstruction range from fatigue and dyspnea to heart failure and sudden death. Cardiac myxomas may not be identified by routine auscultation, and transthoracic and/or transesophageal echocardiography is preferred [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/d/html/4881.html" rel="external">"Cardiac tumors", section on 'Myxomas'</a> and  <a class="medical medical_review" href="/d/html/4881.html" rel="external">"Cardiac tumors"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psammomatous melanotic schwannomas</strong> – Psammomatous melanotic schwannomas may be located anywhere in the central or peripheral nervous system, but in most cases, they occur in the gastrointestinal tract and in the spinal nerve roots. Approximately 20 percent of these tumors associated with CNC are malignant. (See  <a class="medical medical_review" href="/d/html/15269.html" rel="external">"Peripheral nerve tumors", section on 'Schwannoma'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benign breast tumors</strong> – Benign breast tumor, including myxomas, myxoid fibroadenomas, and ductal adenomas with tubular features, have been reported in approximately 14 percent of female patients with CNC [<a href="#rid1">1,24</a>]. They develop after puberty and may be mistaken for fibrocystic breast disease. (See  <a class="medical medical_review" href="/d/html/806.html" rel="external">"Overview of benign breast diseases"</a>.)</p><p></p><p class="headingAnchor" id="H3440856555"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>Skin biopsy is usually not performed for lentiginous pigmentation unless there is a suspicion for malignancy. Histologically, lentigines are characterized by elongation of epidermal ridges with increased pigmentation of the basal layer.</p><p>Cutaneous myxomas demonstrate a nonencapsulated proliferation of spindled or stellate dermal fibroblasts in a loose, mucinous stroma in the dermis. Bizarre multinucleated cells and regular mitotic figures can be seen.</p><p>Blue nevi characteristically demonstrate highly pigmented melanocytes in the superficial and reticular dermis. Large, epithelioid cells with minimal pigmentation and abundant cytoplasm arranged in nests in the dermis are features suggestive of epithelioid blue nevus [<a href="#rid7">7,25</a>].</p><p class="headingAnchor" id="H2013417686"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3750134782"><span class="h2">Clinical suspicion</span><span class="headingEndMark"> — </span>The diagnosis of CNC is suspected in patients presenting with characteristic cutaneous findings, in particular:</p><p class="bulletIndent1"><span class="glyph">●</span>Lentiginosis with periorificial distribution</p><p class="bulletIndent1"><span class="glyph">●</span>Lentigines located on the lid margin or lacrimal caruncle</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple blue nevi or blue nevi with epithelioid histology</p><p class="bulletIndent1"><span class="glyph">●</span>Cutaneous myxoma(s) histologically confirmed</p><p></p><p>The diagnosis should also be suspected in patients with a history of cardiac myxoma, especially if multiple and with onset at a young age, and in patients with concurrent cutaneous lesions and endocrine disease (eg, Cushing's syndrome, gigantism/acromegaly).</p><p class="headingAnchor" id="H2805719520"><span class="h2">Diagnostic criteria</span><span class="headingEndMark"> — </span>Diagnostic criteria for CNC are shown in the table  (<a class="graphic graphic_table graphicRef83442" href="/d/graphic/83442.html" rel="external">table 1</a>) [<a href="#rid4">4</a>]. The diagnosis is established in the following situations [<a href="#rid26">26</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Two or more major criteria are present.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A pathogenic variant is identified in the protein kinase A type I-alpha regulatory subunit (<em>PRKAR1A</em>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One major criterion is present, and a first-degree relative has CNC or an inactivating mutation of <em>PRKAR1A</em>.</p><p></p><p>In patients presenting with cardiac myxomas, immunohistochemical staining of the tumor tissue for loss of <em>PRKAR1A</em> protein expression was proposed as a rapid and sensitive screening method for CNC [<a href="#rid20">20</a>]. However, loss of <em>PRKAR1A</em> staining showed low specificity (68 percent) in a large cohort of sporadic atrial myxomas and also would not identify patients with CNC associated with the 2p16 locus. </p><p class="headingAnchor" id="H2312206295"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>CNC should be differentiated from several genetic syndromes associated with lentiginosis. They are summarized in the tables  (<a class="graphic graphic_table graphicRef66428" href="/d/graphic/66428.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef112348" href="/d/graphic/112348.html" rel="external">table 3</a>) and include [<a href="#rid27">27</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peutz-Jeghers syndrome</strong> – Spotty facial pigmentation, particularly of the lips and oral mucosa, is a hallmark feature of Peutz-Jeghers syndrome (PJS; MIM #175200), an autosomal dominant syndrome characterized by multiple hamartomatous polyps in the gastrointestinal tract, mucocutaneous pigmentation, and an increased risk of gastrointestinal and nongastrointestinal cancer [<a href="#rid28">28</a>]. Both CNC and PJS are associated with thyroid disease and increased risk of large cell calcifying Sertoli cell tumors in males. However, PJS is also strongly associated with early onset gastrointestinal polyposis, as well as markedly elevated risk of gastrointestinal, genitourinary, and other malignancies. Clinically, the lentiginous pigmentation in PJS most commonly occurs on the lips and perioral skin, oral mucosa, rectal mucosa, and palms and soles  (<a class="graphic graphic_picture graphicRef112236" href="/d/graphic/112236.html" rel="external">picture 8</a>) but, in contrast with CNC, usually spares the periocular skin. Moreover, PJS is not associated with cutaneous myxomas or blue nevi. (See  <a class="medical medical_review" href="/d/html/2533.html" rel="external">"Peutz-Jeghers syndrome: Clinical manifestations, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>LEOPARD syndrome</strong> – LEOPARD syndrome (<strong>l</strong>entigines, <strong>E</strong>KG [electrocardiogram] abnormalities, <strong>o</strong>cular hypertelorism, <strong>p</strong>ulmonic stenosis, <strong>a</strong>bnormal genitalia, <strong>r</strong>etardation of growth, and sensorineural <strong>d</strong>eafness), also called progressive cardiomyopathic lentiginosis (MIM #151100), is a rare autosomal dominant disorder caused by mutations in the protein tyrosine phosphatase gene (<em>PTPN11</em>). Multiple, disseminated lentigines are the most prominent feature of LEOPARD syndrome. They appear during infancy and early childhood, increase in number over time, and, in contrast with CNC, tend to involve a large portion of the skin, including the face, neck, and upper trunk  (<a class="graphic graphic_picture graphicRef94195" href="/d/graphic/94195.html" rel="external">picture 9</a>). Cardiac and other systemic abnormalities of LEOPARD are distinct from those seen in CNC. (See  <a class="medical medical_review" href="/d/html/111807.html" rel="external">"Congenital and inherited hyperpigmentation disorders", section on 'LEOPARD syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>PTEN</em></strong><strong> hamartoma tumor syndromes </strong>– The phosphatase and tensin homolog (<em>PTEN</em>) hamartoma tumor syndromes (PHTS) are a group of rare inherited disorders associated with macrocephaly and an increased risk of developing multiple hamartomas in various organ systems, such as the breast, skin, thyroid, central nervous system, and gastrointestinal tract [<a href="#rid29">29,30</a>]. PHTS include Cowden disease and Bannayan-Riley-Ruvalcaba syndrome. The development of lentigines on the glans penis beginning in childhood is considered a marker of Bannayan-Riley-Ruvalcaba syndrome. Distinctive mucocutaneous lesions, including multiple facial trichilemmomas  (<a class="graphic graphic_picture graphicRef98306" href="/d/graphic/98306.html" rel="external">picture 10</a>), oral papillomas  (<a class="graphic graphic_picture graphicRef80290" href="/d/graphic/80290.html" rel="external">picture 11</a>), and acral keratoses, and extracutaneous features (eg, macrocephaly; gastrointestinal hamartomatous polyps; breast, thyroid, and endometrial cancers) distinguish PHTS from CNC. (See  <a class="medical medical_review" href="/d/html/16543.html" rel="external">"PTEN hamartoma tumor syndromes, including Cowden syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>McCune-Albright syndrome</strong> – Perioral and mucosal pigmentation may be also seen in McCune-Albright syndrome, a mosaic disorder caused by postzygotic activating mutations of the <em>GNAS1 </em>gene, encoding the alpha subunit of the stimulatory G protein [<a href="#rid31">31</a>]. The syndrome is characterized by the triad of polyostotic fibrous dysplasia, striking café-au-lait macules  (<a class="graphic graphic_picture graphicRef96333" href="/d/graphic/96333.html" rel="external">picture 12</a>), and endocrine hyperactivity, classically causing precocious puberty. (See  <a class="medical medical_review" href="/d/html/5812.html" rel="external">"Definition, etiology, and evaluation of precocious puberty", section on 'McCune-Albright syndrome'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benign familial lentiginosis</strong> – Patterned lentiginosis is a benign generalized lentiginosis inherited in an autosomal dominant manner in the absence of systemic abnormalities [<a href="#rid32">32</a>]. Lentigines are present on the face, lips, extremities, buttocks, and palms and soles but spare the mucosal surfaces. The condition is common in light‐skinned Black people, especially in those with reddish‐brown hair.</p><p></p><p class="headingAnchor" id="H3251605583"><span class="h1">TREATMENT AND FOLLOW-UP</span><span class="headingEndMark"> — </span>The management of patients with a diagnosis of CNC involves ongoing surveillance to assess the extent of disease and treatment of systemic manifestations and complications:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac myxomas</strong> – Surgical resection is the treatment of choice for cardiac myxomas. They may recur in affected patients; follow-up monitoring is required. (See  <a class="medical medical_review" href="/d/html/4881.html" rel="external">"Cardiac tumors", section on 'Treatment and prognosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cushing's syndrome</strong> – Bilateral adrenalectomy is the recommended treatment for Cushing's syndrome due to primary pigmented nodular adrenocortical disease (PPNAD). (See  <a class="medical medical_review" href="/d/html/152.html" rel="external">"Cushing syndrome due to primary pigmented nodular adrenocortical disease", section on 'Treatment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thyroid nodules</strong> – Fine needle aspiration is indicated for patients with thyroid nodules. Patients with lesions suspicious for malignancy should be referred for surgery. (See  <a class="medical medical_review" href="/d/html/7890.html" rel="external">"Diagnostic approach to and treatment of thyroid nodules"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pituitary adenomas</strong> – Pituitary adenomas are treated with transsphenoidal surgery. (See  <a class="medical medical_review" href="/d/html/86683.html" rel="external">"Transsphenoidal surgery for pituitary adenomas and other sellar masses"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Calcifying Sertoli cell tumors</strong> – In children, most large cell calcifying Sertoli cell tumors (LCCSCTs), especially when bilateral, are benign and require imaging surveillance alone [<a href="#rid12">12</a>]. If measures of tumor markers or imaging features indicate a suspicion for malignancy, then testicle-sparing surgery may be considered for small tumors to allow for histopathologic examination. There are a few reports of prepubertal boys with LCCSCT treated with aromatase inhibitors [<a href="#rid33">33-35</a>]. </p><p></p><p class="bulletIndent1">Malignant LCCSCTs usually occur in older patients (mean age 39 years) and in those who have unilateral and unifocal disease [<a href="#rid12">12</a>]. Orchiectomy is the treatment of choice for malignant LCCSCTs. (See  <a class="medical medical_review" href="/d/html/2972.html" rel="external">"Testicular sex cord stromal tumors", section on 'Management after orchiectomy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psammomatous melanotic schwannomas</strong> – Psammomatous melanotic schwannomas are treated with complete surgical resection with tumor-free margins. Chemotherapy and radiation therapy may be required for malignant tumors. (See  <a class="medical medical_review" href="/d/html/15269.html" rel="external">"Peripheral nerve tumors", section on 'Schwannoma'</a>.)</p><p></p><p>Specific surveillance guidelines for patients with CNC are lacking. Suggested laboratory and imaging evaluations following the diagnosis of CNC may include [<a href="#rid36">36</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Annual echocardiogram for cardiac myxomas in children and adults. This study may be performed every six months in children and adolescents with a history of excised myxoma. (See  <a class="medical medical_review" href="/d/html/4881.html" rel="external">"Cardiac tumors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Annual thyroid ultrasound for thyroid nodules in children and adults.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Annual testicular ultrasound in boys before puberty, with follow-up by a urologist familiar with CNC if nodules are noted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Annual measurement of 24-hour urinary free cortisol (UFC) excretion beginning in adolescence. If PPNAD is suspected despite normal UFC, diurnal cortisol levels and/or dexamethasone-stimulation test, and adrenal computed tomography are indicated. (See  <a class="medical medical_review" href="/d/html/152.html" rel="external">"Cushing syndrome due to primary pigmented nodular adrenocortical disease", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Annual measurement of insulin-like growth factor-1 and prolactin beginning in adolescence to screen for pituitary overactivity. These tests may be performed earlier based upon clinical findings (abnormal growth rate/pubertal staging). (See  <a class="medical medical_review" href="/d/html/5855.html" rel="external">"Pituitary gigantism"</a> and  <a class="medical medical_review" href="/d/html/6635.html" rel="external">"Diagnosis of acromegaly"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Transabdominal ultrasound is recommended in women at the time of diagnosis but does not need to be repeated if normal [<a href="#rid37">37</a>].</p><p></p><p class="headingAnchor" id="H3057036018"><span class="h1">GENETIC COUNSELING</span><span class="headingEndMark"> — </span>Genetic testing for mutations in the protein kinase A type I-alpha regulatory subunit (<em>PRKAR1A</em>) is indicated for other potentially affected family members of patients with CNC. However, clinical surveillance is advisable for at-risk family members even when a <em>PRKAR1A</em> pathogenic variant is not identified. When neither parent of an individual with CNC has the pathogenic gene variant or any clinical features of CNC, the affected patient has likely a de novo mutation. (See  <a class="medical medical_review" href="/d/html/2901.html" rel="external">"Genetic testing"</a>.)</p><p>Counseling regarding the potential risks for the offspring should be offered to adults and to children prior to childbearing age with or at risk for CNC. The availability of prenatal and preimplantation genetic testing should also be discussed. (See  <a class="medical medical_review" href="/d/html/103304.html" rel="external">"Genetic counseling: Family history interpretation and risk assessment"</a>.)</p><p class="headingAnchor" id="H2127968497"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The greatest risk of mortality in CNC is associated with cardiac disease (57 percent), specifically cardiac myxomas and complications of cardiac surgery [<a href="#rid4">4</a>]. Other major causes of mortality include metastatic or intracranial psammomatous melanotic schwannoma (14 percent), carcinoma or metastatic tumor (14 percent), and noncardiac postoperative complications (12 percent) [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H3778654142"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and pathogenesis</strong> – Carney complex (CNC) is a rare multiple neoplasia syndrome associated with distinctive cutaneous lesions. It is caused by inactivating mutations in the protein kinase A type I-alpha regulatory subunit<em> </em>(<em>PRKAR1A</em>) gene and is inherited in an autosomal dominant manner. (See <a class="local">'Introduction'</a> above and <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cutaneous</strong> – Lentiginous skin pigmentation is the most readily identifiable sign of CNC and is found in 70 to 80 percent of patients. Lentigines often have a periorificial distribution and may be found on the lid margin and lacrimal caruncle. Other distinctive skin lesions include dark "ink spot" lentigines, multiple blue nevi, especially histologically epithelioid blue nevi, and cutaneous myxomas. Cutaneous myxomas are less frequently seen in patients with CNC. They are benign dermal tumors presenting as sharply demarcated subcutaneous nodules, a few millimeters to 1.5 cm in diameter  (<a class="graphic graphic_picture graphicRef112112 graphicRef112113 graphicRef112123 graphicRef112124 graphicRef112125" href="/d/graphic/112112.html" rel="external">picture 7A-E</a>). (See <a class="local">'Skin'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Extracutaneous</strong> – Systemic manifestations of CNC result from endocrine and nonendocrine tumors. Endocrine tumors include primary pigmented nodular adrenocortical disease (PPNAD), testicular large cell calcifying Sertoli tumors, growth hormone-secreting pituitary adenomas, thyroid adenomas and carcinomas, and ovarian cysts. Rare but highly characteristic nonendocrine tumors associated with CNC include cardiac myxomas, psammomatous melanotic schwannomas, breast ductal adenomas, and osteochondromyxomas. (See <a class="local">'Endocrine tumors'</a> above and <a class="local">'Nonendocrine tumors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Diagnostic criteria for CNC are shown in the table  (<a class="graphic graphic_table graphicRef83442" href="/d/graphic/83442.html" rel="external">table 1</a>). The diagnosis is established in patients with two or more major clinical criteria and in patients in whom a pathogenetic variant is identified in <em>PRKAR1A</em>. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Management of patients with a diagnosis of CNC involves ongoing surveillance to assess the extent of disease and treatment of systemic manifestations and complications. Surgical resection is the mainstay of treatment of endocrine and nonendocrine tumors associated with CNC. (See <a class="local">'Treatment and follow-up'</a> above.)</p><p></p><p class="headingAnchor" id="H2227873047"><span class="h1">ACKNOWLEGMENT</span><span class="headingEndMark"> — </span>The views expressed in this topic are those of the author(s) and do not reflect the official views or policy of the National Institutes of Health or the United States Government or its components.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Correa R, Salpea P, Stratakis CA. Carney complex: an update. Eur J Endocrinol 2015; 173:M85.</a></li><li class="breakAll">Stratakis CA, Raygada M. Carney complex. In: GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle, 1993.</li><li><a class="nounderline abstract_t">Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med 2009; 266:43.</a></li><li><a class="nounderline abstract_t">Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001; 86:4041.</a></li><li><a class="nounderline abstract_t">Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000; 26:89.</a></li><li><a class="nounderline abstract_t">Bertherat J, Horvath A, Groussin L, et al. Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab 2009; 94:2085.</a></li><li><a class="nounderline abstract_t">Mateus C, Palangié A, Franck N, et al. Heterogeneity of skin manifestations in patients with Carney complex. J Am Acad Dermatol 2008; 59:801.</a></li><li><a class="nounderline abstract_t">Shen Z, Hoffman JD, Hao F, Pier E. More than just skin deep: faciocutaneous clues to genetic syndromes with malignancies. Oncologist 2012; 17:930.</a></li><li><a class="nounderline abstract_t">Cohen C, Turner ML, Stratakis CA. Pigmented lesions of the conjunctiva in Carney's complex. J Am Acad Dermatol 2000; 42:145.</a></li><li><a class="nounderline abstract_t">Lonser RR, Mehta GU, Kindzelski BA, et al. Surgical Management of Carney Complex-Associated Pituitary Pathology. Neurosurgery 2016.</a></li><li><a class="nounderline abstract_t">Idrees MT, Ulbright TM, Oliva E, et al. The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology 2017; 70:513.</a></li><li><a class="nounderline abstract_t">Gourgari E, Saloustros E, Stratakis CA. Large-cell calcifying Sertoli cell tumors of the testes in pediatrics. Curr Opin Pediatr 2012; 24:518.</a></li><li><a class="nounderline abstract_t">Kaluzny A, Matuszewski M, Wojtylak S, et al. Organ-sparing surgery of the bilateral testicular large cell calcifying sertoli cell tumor in patient with atypical Peutz-Jeghers syndrome. Int Urol Nephrol 2012; 44:1045.</a></li><li><a class="nounderline abstract_t">Stratakis CA. Hereditary syndromes predisposing to endocrine tumors and their skin manifestations. Rev Endocr Metab Disord 2016; 17:381.</a></li><li><a class="nounderline abstract_t">Papageorgiou T, Stratakis CA. Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease). Int J Gynecol Cancer 2002; 12:337.</a></li><li><a class="nounderline abstract_t">Golden T, Siordia JA. Osteochondromyxoma: Review of a rare carney complex criterion. J Bone Oncol 2016; 5:194.</a></li><li><a class="nounderline abstract_t">Carney JA, Toorkey BC. Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Am J Surg Pathol 1991; 15:722.</a></li><li><a class="nounderline abstract_t">Shields LB, Glassman SD, Raque GH, Shields CB. Malignant psammomatous melanotic schwannoma of the spine: A component of Carney complex. Surg Neurol Int 2011; 2:136.</a></li><li><a class="nounderline abstract_t">Shetty Roy AN, Radin M, Sarabi D, Shaoulian E. Familial recurrent atrial myxoma: Carney's complex. Clin Cardiol 2011; 34:83.</a></li><li><a class="nounderline abstract_t">Maleszewski JJ, Larsen BT, Kip NS, et al. PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors. Am J Surg Pathol 2014; 38:1079.</a></li><li><a class="nounderline abstract_t">Irani AD, Estrera AL, Buja LM, Safi HJ. Biatrial myxoma: a case report and review of the literature. J Card Surg 2008; 23:385.</a></li><li><a class="nounderline abstract_t">Pitsava G, Zhu C, Sundaram R, et al. Predicting the risk of cardiac myxoma in Carney complex. Genet Med 2021; 23:80.</a></li><li><a class="nounderline abstract_t">O'Rourke F, Dean N, Mouradian MS, et al. Atrial myxoma as a cause of stroke: case report and discussion. CMAJ 2003; 169:1049.</a></li><li><a class="nounderline abstract_t">Carney JA, Stratakis CA. Ductal adenoma of the breast and the Carney complex. Am J Surg Pathol 1996; 20:1154.</a></li><li><a class="nounderline abstract_t">Izquierdo MJ, Pastor MA, Carrasco L, et al. Epithelioid blue naevus of the genital mucosa: report of four cases. Br J Dermatol 2001; 145:496.</a></li><li><a class="nounderline abstract_t">Almeida MQ, Stratakis CA. Carney complex and other conditions associated with micronodular adrenal hyperplasias. Best Pract Res Clin Endocrinol Metab 2010; 24:907.</a></li><li><a class="nounderline abstract_t">Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes. Fam Cancer 2011; 10:481.</a></li><li><a class="nounderline abstract_t">Jelsig AM, Qvist N, Brusgaard K, et al. Hamartomatous polyposis syndromes: a review. Orphanet J Rare Dis 2014; 9:101.</a></li><li><a class="nounderline abstract_t">Mester JL, Tilot AK, Rybicki LA, et al. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet 2011; 19:763.</a></li><li class="breakAll">Eng C. PTEN hamartoma tumor syndrome. In: GeneReviews, Adam MP, Ardinger HH, Pagon RA, et al (Eds), University of Washington, Seattle, 1993.</li><li><a class="nounderline abstract_t">Pichard DC, Boyce AM, Collins MT, Cowen EW. Oral pigmentation in McCune-Albright syndrome. JAMA Dermatol 2014; 150:760.</a></li><li><a class="nounderline abstract_t">O'Neill JF, James WD. Inherited patterned lentiginosis in blacks. Arch Dermatol 1989; 125:1231.</a></li><li><a class="nounderline abstract_t">Crocker MK, Gourgari E, Lodish M, Stratakis CA. Use of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone age. J Clin Endocrinol Metab 2014; 99:E2673.</a></li><li><a class="nounderline abstract_t">Koç Yekedüz M, Şıklar Z, Burgu B, et al. RESPONSE TO THE ANASTROZOLE TREATMENT IN A CASE WITH PEUTZ-JEGHERS SYNDROME WHO WAS DETECTED TO HAVE LARGE CELL CALCIFYING SERTOLI CELL TUMOR AND DEVELOPED PRE-PUBERTAL GYNECOMASTIA. J Clin Res Pediatr Endocrinol 2016.</a></li><li><a class="nounderline abstract_t">Grandone A, del Giudice EM, Cirillo G, et al. Prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: two years' treatment with anastrozole and genetic study. Horm Res Paediatr 2011; 75:374.</a></li><li><a class="nounderline abstract_t">Stratakis CA. Carney complex: A familial lentiginosis predisposing to a variety of tumors. Rev Endocr Metab Disord 2016; 17:367.</a></li><li><a class="nounderline abstract_t">Kamilaris CDC, Faucz FR, Voutetakis A, Stratakis CA. Carney Complex. Exp Clin Endocrinol Diabetes 2019; 127:156.</a></li></ol></div><div id="topicVersionRevision">Topic 100662 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26130139" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Carney complex: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26130139" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Carney complex: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19522824" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11549623" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10973256" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19293268" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18804312" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Heterogeneity of skin manifestations in patients with Carney complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22707513" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : More than just skin deep: faciocutaneous clues to genetic syndromes with malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10607338" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pigmented lesions of the conjunctiva in Carney's complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27509071" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Surgical Management of Carney Complex-Associated Pituitary Pathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27801954" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22732638" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Large-cell calcifying Sertoli cell tumors of the testes in pediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22160729" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Organ-sparing surgery of the bilateral testicular large cell calcifying sertoli cell tumor in patient with atypical Peutz-Jeghers syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27943006" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Hereditary syndromes predisposing to endocrine tumors and their skin manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12144681" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28008382" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Osteochondromyxoma: Review of a rare carney complex criterion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2069210" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22059131" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Malignant psammomatous melanotic schwannoma of the spine: A component of Carney complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21298650" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Familial recurrent atrial myxoma: Carney's complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24618615" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18384573" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Biatrial myxoma: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32893266" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Predicting the risk of cardiac myxoma in Carney complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14609975" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Atrial myxoma as a cause of stroke: case report and discussion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8764753" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Ductal adenoma of the breast and the Carney complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11531845" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Epithelioid blue naevus of the genital mucosa: report of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21115159" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Carney complex and other conditions associated with micronodular adrenal hyperplasias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21538076" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The differential diagnosis of familial lentiginosis syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25022750" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Hamartomatous polyposis syndromes: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343951" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343951" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24671640" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Oral pigmentation in McCune-Albright syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2673048" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Inherited patterned lentiginosis in blacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25226294" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Use of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27873740" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : RESPONSE TO THE ANASTROZOLE TREATMENT IN A CASE WITH PEUTZ-JEGHERS SYNDROME WHO WAS DETECTED TO HAVE LARGE CELL CALCIFYING SERTOLI CELL TUMOR AND DEVELOPED PRE-PUBERTAL GYNECOMASTIA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21335955" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: two years' treatment with anastrozole and genetic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27943004" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Carney complex: A familial lentiginosis predisposing to a variety of tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30428497" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Carney Complex.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
